Rong Yang
Director/Board Member bij NATURE'S SUNSHINE PRODUCTS, INC.
Vermogen: 462 112 $ op 31-03-2024
Profiel
Rong Yang is currently the Chief Executive Officer at Fosun Pharma USA, Inc. and an Independent Director at Nature's Sunshine Products, Inc. Yang holds a Master's in Business Administration from Harvard University, an undergraduate degree from Beijing Foreign Studies University, and a graduate degree from Nankai University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
06-05-2024 | 22 249 ( 0.12% ) | 462 112 $ | 31-03-2024 |
Actieve functies van Rong Yang
Bedrijven | Functie | Begin |
---|---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Director/Board Member | 01-06-2022 |
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Chief Executive Officer | 01-01-2022 |
Opleiding van Rong Yang
Harvard University | Masters Business Admin |
Beijing Foreign Studies University | Undergraduate Degree |
Nankai University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NATURE'S SUNSHINE PRODUCTS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Fosun Pharma USA, Inc.
Fosun Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Fosun Pharma USA, Inc. is a fast-growing pharmaceutical company that was founded in 2017. The private company is based in Princeton, NJ. The company, which is a subsidiary of Fosun Pharma, continually works to enhance its existing portfolio of specialty pharmaceutical injectables and to build its pipeline with both innovative and generic pharmaceutical drugs. Fosun Pharma USA is dedicated to bringing products to market to improve patient access to medicine and innovation. Rong Yang has been the CEO of the company since 2022. | Health Technology |